ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control) Recall
ADVIA¿ 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)
FDA recall Class II
Ongoing
FDA lists this Class II recall for ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control). Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2089-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 4, 2025
- FDA report date
- Jul 9, 2025
- Quantity in commerce
- 3,266 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)
Affected model & UDI checker
Search the exact identifiers published for Z-2089-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control) | Check source notice | 00630414473413 |
FDA code information
Siemens Material Number 10318905; UDI: 00630414473413, 00630414473413; Lot No. TP253035, TP253045.
Why was this product recalled?
Products have the incorrect platelet (PLT) value assignments for the ADVIA 120/2120/2120i Hematology Systems.
What actions did Siemens Healthcare Diagnostics, Inc. take?
An Urgent Medical Device Correction notification dated 6/4/25 was mailed to consignees. This notification provides consignees with calibration instructions given the issue found in affected lots. Additionally, instructions are given on how to proceed with product depending on performance. Consignees are to discontinue use of and discard of the calibrator SETPOINT lots impacted by this recall. Consignee locations are to review the provided notification with their Medical Directors to determine the appropriate course of action. A copy of the recall notification should be retained in laboratory records and shared with users. Consignees are to complete and return the provided Effectiveness Check Form within 30 days of receipt of the recall notification. Consignees with any questions can contact their Siemens Customer Care Center or local Siemens Healthineers technical support representative.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2089-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology